Home » Topics » Conferences

Conferences
RSS

L-Arginine not associated with objective improvement in organic ED

Oct. 3, 1997

Linsidomine + moxisylyte for ED

Oct. 3, 1997

Effects of BQ-123 and BQ-788 on ET-1-induced corpus cavernosum contractions

Oct. 3, 1997

Intracavernous moxisylyte recommended for first-line treatment of ED

Oct. 3, 1997

Korean researchers present novel 3-isoxazolylvinylcephalosporins

Oct. 3, 1997

R.W. Johnson identifies TCS inhibitor with potent antibacterial activity

Oct. 3, 1997

Microcide identifies cephalosporin with excellent Gram-positive activity

Oct. 3, 1997

Novel antibacterial agents that inhibit bacterial two-component systems

Oct. 3, 1997

Wakunaga prepares acidic fluoroquinolone

Oct. 3, 1997

Triazole antifungal from Uriach heading for clinic

Oct. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026